EU AI Act Amendments Get Green Light From Parliament Committees In Latest Vote

The European Commission’s hotly debated AI Act proposal is a step closer to becoming law after 13 amendments were voted in by members of the European Parliament. The landmark legislation is set to have an enormous impact on all AI products, including many medical devices.

EU Vote
• Source: Shutterstock

A wave of claps erupted in the European Parliament this morning after members voted by a “large majority” in favor of 13 amendments to the Artificial Intelligence (AI) Act, meaning the controversial regulatory proposal is one step closer to becoming law. This development is one that is set to have large implications for the medtech sector, as once the AI Act is adopted it will set new compliance requirements for many medical devices (more below.)

In total, 84 members of the Internal Market and Consumer Protection (IMCO) and the Civil Liberties, Justice and Home Affairs...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

German Health Researchers Prep for Possible Disruptions to PubMed, ClinicalTrials.gov

 

IQWiG, Germany’s health technology assessment body, is making contingency plans in case key US resources it relies on for information retrieval, when conducting benefit assessments of new medicines, become unavailable.

Hip Resurfacing For Women: Embody Orthopaedic Awarded CE Mark For H1 Implant

 

The ceramic device, designed to reduce complications, will be exclusively distributed by Zimmer Biomet and initially available in 30 hospitals, with broader European access expected by 2026.

German Hospital Reform Risks Spiraling Out Of Control

 
• By 

Amendments to Germany’s – barely in force – health reform law will be decided after the summer break. The new DRGs payments plan and service groups will be reviewed, but critics fear for the law’s future.

Why EU Innovators Face Growing Barriers With EU Combination Product Regulation

 

Combination products are no longer fringe – they are the “new normal,” consultant Stephen O’Rourke told Medtech Insight. The EU has the expertise to handle the regulatory complexity, but only if connects the dots between silos. That’s the challenge, he said, and the opportunity.

More from Geography

Dexcom Nabs Weight Management Indication For Signos CGM

 

Signos links users to Dexcom’s Stelo for glucose readings and historic trends. The app is available in iOS and Android from the firm’s website, where it’s priced at $139 for three-month plan and $129 for a two-month plan, or online app stores.

SetPoint Medical Raises $140M: Pipeline Expansion And Multiple Sclerosis Clinical Trial On Horizon

 

SetPoint Medical secured US FDA approval for its vagus nerve neuromodulation device to treat RA. Now, the start-up is tasked with convincing both rheumatologist and surgeons to adopt its technology over or alongside biologic drugs. CEO Murthy Simhambhatla talks exit strategy plans.

German Health Researchers Prep for Possible Disruptions to PubMed, ClinicalTrials.gov

 

IQWiG, Germany’s health technology assessment body, is making contingency plans in case key US resources it relies on for information retrieval, when conducting benefit assessments of new medicines, become unavailable.